BDNF Signaling in Vascular Dementia and Its Effects on Cerebrovascular Dysfunction, Synaptic Plasticity, and Cholinergic System Abnormality
10.12997/jla.2024.13.2.122
- Author:
Juhyun SONG
1
Author Information
1. Department of Anatomy, Chonnam National University Medical School, Hwasun, Korea
- Publication Type:Review
- From:Journal of Lipid and Atherosclerosis
2024;13(2):122-138
- CountryRepublic of Korea
- Language:English
-
Abstract:
Vascular dementia (VaD) is the second most common type of dementia and is characterized by memory impairment, blood–brain barrier disruption, neuronal cell loss, glia activation, impaired synaptic plasticity, and cholinergic system abnormalities. To effectively prevent and treat VaD a good understanding of the mechanisms underlying its neuropathology is needed.Brain-derived neurotrophic factor (BDNF) is an important neurotrophic factor with multiple functions in the systemic circulation and the central nervous system and is known to regulate neuronal cell survival, synaptic formation, glia activation, and cognitive decline. Recent studies indicate that when compared with normal subjects, patients with VaD have low serum BDNF levels and that BDNF deficiency in the serum and cerebrospinal fluid is an important indicator of VaD. Here, we review current knowledge on the role of BDNF signaling in the pathology of VaD, such as cerebrovascular dysfunction, synaptic dysfunction, and cholinergic system impairment.
